Clarus Therapeutics Funding: $47M Raised, Series C (2014)
Clarus Therapeutics is based in Northbrook. It has raised $47M in total funding. Latest round: Series C.
Clarus Therapeutics funding overview
Clarus Therapeutics is based in Northbrook. Clarus Therapeutics has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2014. The round record for Clarus Therapeutics runs through 2014; nothing later has been disclosed. Investors on record include C-Bridge Capital, BioVeda Capital, Pavilion Capital, H.I.G. Ventures, Thomas, McNerney & Partners. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Clarus Therapeutics funding
How much has Clarus Therapeutics raised?
Clarus Therapeutics has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Clarus Therapeutics?
C-Bridge Capital, BioVeda Capital, Pavilion Capital, H.I.G. Ventures, Thomas, McNerney & Partners are named among the investors backing Clarus Therapeutics.
What was the latest Clarus Therapeutics funding round?
The most recent disclosed round is a Series C, announced in June 2014.
Where is Clarus Therapeutics based?
Clarus Therapeutics is based in Northbrook.
When did Clarus Therapeutics last raise?
The last disclosed Clarus Therapeutics round closed in June 2014 at Series C.
We update the Clarus Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Northbrook and their backers are listed below.
